This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

UCI-created stem cell therapy is basis of proposed first-ever trial

November 23rd, 2010

(PhysOrg.com) -- StemCells Inc. has filed an application with the Swiss regulatory agency for therapeutic products to conduct the world's first clinical study of a human neural stem cell-based treatment in chronic spinal cord injury patients.

StemCells Inc. has filed an application with Swissmedic, the Swiss regulatory agency for therapeutic products, to conduct the world's first clinical trial of a human neural stem cell-based therapy in chronic spinal cord injury patients. Aileen Anderson and Brian Cummings of the Sue and Bill Gross Stem Cell Research Center at UCI collaborated with StemCells Inc. to develop the therapy, in which purified human neural stem cells introduced into the spinal column grow into neural tissue cells that migrate to spinal cord injury sites. Previously, Anderson and Cummings published studies showing how the therapy restored mobility in mice during the later chronic phase of spinal cord injury, in which inflammation has stabilized and recovery has reached a plateau. If authorized, the Switzerland-based study will enroll patients who are three to 12 months post-injury.

More information:
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0012272

Provided by UC Irvine

Citation: UCI-created stem cell therapy is basis of proposed first-ever trial (2010, November 23) retrieved 16 August 2026 from https://sciencex.com/wire-news/51962743/uci-created-stem-cell-therapy-is-basis-of-proposed-first-ever-tr.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.